Mitchell & Pahl Private Wealth, LLC Astrazeneca PLC Transaction History

Mitchell & Pahl Private Wealth, LLC

$207 Million
Q1 2025

A detailed history of Mitchell & Pahl Private Wealth, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Mitchell & Pahl Private Wealth, LLC holds 13,651 shares of AZN stock, worth $922,671. This represents 0.48% of its overall portfolio holdings.

Number of Shares

13,651

Previous 13,872 1.59%

Holding current value

$922,671

Previous $908,000 10.46%

% of portfolio

0.48%

Previous 0.44%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 09, 2025	SELL	$65.37 - $77.96 $14,446 - $17,229	-221 Reduced 1.59%	13,651 $1 Million
Q4 2024 Jan 16, 2025	BUY	$63.2 - $79.58 $48,727 - $61,356	771 Added 5.89%	13,872 $908,000
Q3 2024 Oct 16, 2024	SELL	$76.67 - $87.62 $3,910 - $4,468	-51 Reduced 0.39%	13,101 $1.02 Million
Q2 2024 Jul 12, 2024	SELL	$66.81 - $80.83 $7,349 - $8,891	-110 Reduced 0.83%	13,152 $1.03 Million
Q1 2024 Apr 26, 2024	BUY	$61.03 - $69.57 $43,758 - $49,881	717 Added 5.72%	13,262 $898,000
Q4 2023 Feb 08, 2024	SELL	$61.89 - $69.28 $13,863 - $15,518	-224 Reduced 1.75%	12,545 $844,000
Q3 2023 Oct 31, 2023	BUY	$64.85 - $71.7 $79,570 - $87,975	1,227 Added 10.63%	12,769 $864,000
Q2 2023 Aug 07, 2023	BUY	$69.91 - $75.81 $12,863 - $13,949	184 Added 1.62%	11,542 $826,000
Q1 2023 May 05, 2023	BUY	$63.15 - $71.6 $12,061 - $13,675	191 Added 1.71%	11,358 $788,000
Q4 2022 Feb 09, 2023	BUY	$54.21 - $70.44 $73,942 - $96,080	1,364 Added 13.91%	11,167 $757,000
Q3 2022 Nov 01, 2022	BUY	$53.02 - $135.75 $24,442 - $62,580	461 Added 4.93%	9,803 $538,000
Q2 2022 Jul 25, 2022	BUY	$59.26 - $71.14 $14,459 - $17,358	244 Added 2.68%	9,342 $617,000
Q1 2022 Apr 14, 2022	BUY	$55.72 - $67.12 $65,861 - $79,335	1,182 Added 14.93%	9,098 $604,000
Q4 2021 Jan 19, 2022	BUY	$54.02 - $63.83 $32,249 - $38,106	597 Added 8.16%	7,916 $461,000
Q3 2021 Nov 03, 2021	BUY	$55.56 - $60.79 $11,112 - $12,158	200 Added 2.81%	7,319 $440,000
Q2 2021 Jul 14, 2021	BUY	$48.42 - $60.18 $17,382 - $21,604	359 Added 5.31%	7,119 $426,000
Q1 2021 Apr 29, 2021	BUY	$47.16 - $54.44 $24,334 - $28,091	516 Added 8.26%	6,760 $336,000
Q4 2020 Feb 09, 2021	BUY	$48.52 - $58.02 $302,958 - $362,276	6,244 New	6,244 $312,000

Others Institutions Holding AZN

# of Institutions

1,380

Shares Held

476M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $209B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell & Pahl Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell & Pahl Private Wealth, LLC with notifications on news.

Account

Mitchell & Pahl Private Wealth, LLC Astrazeneca PLC Transaction History